Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel in Advanced/Recurrent Esophageal Cancer
NCT00344552Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2006
- Primary completion
- Mar 2008
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in esophageal cancer, sponsored by Bristol Myers Squibb. Started Jun 2006; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00344552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00344552.